Zantac / Ranitidine (NDMA Cancer) Lawsuit in Delaware

Time limits apply in Delaware. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: March 2, 2026How we research

Last reviewed against primary sources: March 2, 2026

Statute of Limitations

Delaware imposes a 2-year statute of limitations for personal injury claims (10 Del. C. § 8119). The discovery rule applies. Delaware applies the Daubert standard under D.R.E. 702, but Judge Medinilla in the Delaware Superior Court Zantac coordination has allowed plaintiffs' causation experts to proceed, distinguishing Delaware from the federal MDL's Daubert exclusion. Delaware is the primary active national venue for Zantac litigation as of 2025-2026.

2 years from date of cancer diagnosis discovery (Delaware Superior Court — most favorable active venue)

Delaware Data

Exposure in Delaware

Source: Delaware Superior Court dockets 2025

Source: Delaware Superior Court case management orders

Medical Resources

Clinics & Specialists in Delaware

Helen F. Graham Cancer Center & Research Institute (ChristianaCare)

Tunnel Cancer Center (Beebe Healthcare)